CS
KRMD icon

Credit Suisse’s KORU Medical Systems KRMD Stock Holding History

Credit Suisse’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,366
Closed -$104K – 4393
2020
Q3 		$104K Buy
+14,366
New +$127K ﹤0.01% 3921

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's KRMD Position: Q4 2020 in Review

Credit Suisse sold out of KORU Medical Systems (KRMD) in Q4 2020, closing a stake of 14,366 shares — an estimated $104K sold.

Credit Suisse first reported a position in KRMD in Q3 2020 and held it in 1 quarter. The position peaked at $104K in Q3 2020. 75 funds tracked by Wall St. Rank hold KRMD as of Q4 2020.

  • Credit Suisse reported no remaining KORU Medical Systems position as of Q4 2020 after selling out during the quarter.
  • Credit Suisse sold 14,366 KORU Medical Systems shares in Q4 2020, an estimated $104K.
  • Credit Suisse first reported a position in KORU Medical Systems in Q3 2020 and held it in 1 quarter.
  • Credit Suisse's KORU Medical Systems position peaked at $104K in Q3 2020.
  • 75 funds tracked by Wall St. Rank held KORU Medical Systems as of Q4 2020.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.